PMID: 4886081Mar 15, 1968Paper

Pathogenesis of a local graft versus host reaction: immunogenicity of circulating host leukocytes

Science
W L Elkins, R D Guttmann

Abstract

A local invasive-destructive reaction typical of that seen in allograft rejection occurs when Lewis rat spleen cells are inoculated under the capsule of Lewis kidney freshly grafted into F(1) hybrid hosts. Thus the donor lymphoid cells can be immunogenically stimulated by circulating host leukocytes and the interaction of these two cell populations results in nonspecific damage to kidney parenchyma. The results indicate that passenger leukocytes in organ allografts may be important immunogenic agents.

References

Nov 1, 1967·The Journal of Experimental Medicine·J D Feldman, S Lee
Nov 1, 1965·The Journal of Experimental Medicine·H R HilgardR A Good
Apr 1, 1967·The Journal of Experimental Medicine·G Holm, P Perlmann
Sep 1, 1964·The Journal of Experimental Medicine·W L ELKINS
Jan 20, 1962·British Medical Journal·N W NISBET, B F HESLOP

❮ Previous
Next ❯

Citations

Mar 1, 1983·Survey of Ophthalmology·L S Braude, J W Chandler
Jun 1, 1990·Journal of Reproductive Immunology·S Kamel, G W Wood
Mar 20, 1999·Transplantation Proceedings·T E StarzlA Rao
Dec 1, 1999·Transplantation Proceedings·F T Rapaport
Apr 11, 2001·Journal of the American College of Surgeons·T E Starzl
Mar 22, 2002·Nature Reviews. Immunology·T E Starzl, R M Zinkernagel
Nov 21, 2000·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·N IchikawaN Murase
Nov 1, 1979·The New England Journal of Medicine·R D Guttmann
Dec 24, 1998·The New England Journal of Medicine·T E Starzl, R M Zinkernagel
Jul 1, 1970·The Journal of Experimental Medicine·J W Streilein, R E Billingham
Nov 1, 1970·The Journal of Experimental Medicine·P B Lambert, H A Frank
Jul 1, 1972·The Journal of Experimental Medicine·J N SinghA H Sehon
May 1, 1979·The Journal of Experimental Medicine·J E Gose, F H Bach
Sep 1, 1995·British Journal of Haematology·C ShustikR Loertscher
Jan 1, 1974·Annals of the New York Academy of Sciences·F T Valentine
Jul 9, 1998·Plastic and Reconstructive Surgery·P E ButlerM J Yaremchuk
Feb 1, 1971·Cellular Immunology·R E Billingham
Aug 20, 1982·The Journal of Comparative Neurology·A A ZalewskiA K Gulati
Jan 1, 1988·Annals of the New York Academy of Sciences·D SteinmullerS J Galli
Oct 1, 1987·Diabetes/metabolism Reviews·A NajiC F Barker
Apr 21, 2018·Transplantation·Sarah J RosenMark A Hardy
Jan 1, 1984·Immunological Reviews·R D Forbes, R D Guttmann
Sep 9, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jean KwunStuart J Knechtle
Sep 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·William F N ChanColin C Anderson
Nov 21, 2018·Frontiers in Immunology·Jacqueline H Y SiuGavin J Pettigrew
Jan 1, 1971·Acta Pathologica Et Microbiologica Scandinavica. Section A, Pathology·I Heron
Jun 15, 2020·The Journal of Thoracic and Cardiovascular Surgery·Michael K Y Hsin, Mingyao Liu
Feb 21, 1981·Lancet·A Aynsley-Green
Feb 21, 1981·Lancet·A M Mowat, A Ferguson
Jul 1, 1980·The Journal of Investigative Dermatology·D Steinmuller
Dec 25, 1970·Science·S Solliday, F H Bach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.